Previous Article | Next Article 
Journal of Bacteriology, August 2003, p. 4992-4996, Vol. 185, No. 16
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.16.4992-4996.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
A Burkholderia pseudomallei Type III Secreted Protein, BopE, Facilitates Bacterial Invasion of Epithelial Cells and Exhibits Guanine Nucleotide Exchange Factor Activity
Mark P. Stevens,1 Andrea Friebel,2 Lowrie A. Taylor,1 Michael W. Wood,1 Philip J. Brown,1,
Wolf-Dietrich Hardt,2 and Edouard E. Galyov1*
Division of Environmental Microbiology, Institute for Animal Health, Compton Laboratory, Berkshire RG20 7NN, United Kingdom,1
Institute of Microbiology, Swiss Federal Institute of Technology Zurich, ETH Zentrum, CH-8092 Zurich, Switzerland2
Received 24 March 2003/
Accepted 12 May 2003

ABSTRACT
We report the characterization of BopE, a type III secreted
protein that is encoded adjacent to the
Burkholderia pseudomallei bsa locus and is homologous to
Salmonella enterica SopE/SopE2.
Inactivation of
bopE impaired bacterial entry into HeLa cells,
indicating that BopE facilitates invasion. Consistent with this
notion, BopE expressed in eukaryotic cells induced rearrangements
in the subcortical actin cytoskeleton, and purified BopE exhibited
guanine nucleotide exchange factor activity for Cdc42 and Rac1
in vitro.

TEXT
Burkholderia pseudomallei is the etiological agent of melioidosis,
a severe invasive infection of humans and animals that is endemic
in subtropical areas (
3,
6). Melioidosis has a remarkable capacity
for latency. Development of disease 26 years after geographical
exposure has been reported (
21), and relapse is common even
in patients treated with antibiotics (
4). This is believed to
result from the ability of
B. pseudomallei to invade nonphagocytic
host cells and to survive and replicate within phagocytes, where
antibiotics may be less effective (
14,
16,
25). The mechanism
by which
B. pseudomallei enters epithelial cells is poorly understood.
We and others have identified a putative type III protein secretion apparatus in B. pseudomallei (Bsa) similar to the Salmonella enterica Inv/Spa/Prg and Shigella flexneri Ipa/Mxi/Spa systems (1, 26, 31). Type III secretion systems are key virulence determinants of Salmonella, Shigella, and other gram-negative facultative intracellular pathogens and serve to inject bacterial proteins into target cells (reviewed in references 5, 10, 13, and 29). A subset of type III secretion system secreted proteins (translocators) is believed to interact with the eukaryotic cell membrane and mediate the delivery of secreted effector proteins. Once inside host cells the effector proteins subvert host cell processes to the benefit of the bacteria (reviewed in references 5 and 13).
Research in our laboratory and elsewhere has identified a number of Salmonella Inv/Spa/Prg secreted effector proteins (Sops) and shown that several of these are delivered into eukaryotic cells by mechanisms dependent on secreted translocator proteins (Sips) (11, 34, 35). Mutations that disrupt the Inv/Spa/Prg apparatus and selected sip and sop genes inhibit bacterial invasion of epithelial cells and Salmonella-induced enteritis (reviewed in references 10, 33, and 36). Some Sop effector proteins possess eukaryote-like enzymatic activities. In particular, it has been shown that the SopE and SopE2 proteins promote bacterial invasion (2, 35) by acting as guanine nucleotide exchange factors (GEFs) for RhoGTPases that regulate the actin network (12, 27, 30). SopE acts as a GEF for Cdc42, Rac1, and Rab5 (8, 9, 12, 23, 27); however, SopE2 efficiently activates Cdc42 but not Rac1 (8, 30), indicating that SopE and SopE2 may activate different signaling cascades during Salmonella infection. Mutation of Salmonella sopE and sopE2 reduces the induction of intestinal inflammatory and secretory responses in calves, suggesting that they play a role in Salmonella-induced enteritis (36, 37).
Recently we reported that mutations affecting putative components of the B. pseudomallei Bsa secretion and translocation apparatus impair intracellular survival of B. pseudomallei in murine macrophage-like cells and prevent escape of the bacteria from endocytic vesicles (31). Here we have investigated the role of a putative Bsa-secreted protein (BopE) that shares homology with the Salmonella SopE/SopE2 proteins. BopE is 27% identical over 168 amino acids to SopE and 28% identical over 139 amino acids to SopE2.
BopE is secreted by the Bsa type III secretion apparatus.
To study expression and secretion of BopE, a BopE-glutathione-S-transferase fusion protein was generated and polyclonal antiserum was raised against BopE in rabbits. A DNA fragment encoding the domain of BopE proposed to be required for GEF activity (amino acid residues 78 to 261) was amplified using the primers BopEGexBam (5'-CGGCAGCTATGGATCCACGGGCGACGCGAAAC-3') and BopEGexE1 (5'-CCACGCTGAATTCTCACGCGCCGTCC-3') and the product cloned into pGEX-2T (Amersham Biosciences, Little Chalfont, Buckinghamshire, England) via EcoRI and BamHI sites (underlined) in the primers. Following expression in Escherichia coli BL21(DE3) under isopropyl-ß-D-thiogalactoside induction, the fusion protein was purified using glutathione Sepharose 4B resin and BopE78-261 released from glutathione-S-transferase by thrombin digestion. A 12-week-old New Zealand White rabbit was immunized subcutaneously four times at 2-week intervals with ca. 100 µg of purified BopE78-261 in Freund's incomplete adjuvant and serum collected 12 days after the final booster.
The BopE-specific antiserum was used to detect BopE in whole-cell and secreted protein fractions of B. pseudomallei strain 10276 and defined bsaZ, bipD, and bopE mutant strains described previously (31). BsaZ and BipD are homologous to the Salmonella SpaS and SipD proteins involved in secretion and translocation of Sop proteins, respectively. Bacteria were grown to stationary phase in Luria-Bertani broth, and culture supernatants were passed through 0.22-µm-pore-size filters prior to precipitation of secreted proteins with trichloroacetic acid (10% [vol/vol]). Approximately 25 µg of total protein (Fig. 1A) or secreted protein (Fig. 1B) was resolved by 4-to-15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to Immobilon-P membrane (Millipore, Bedford, Mass.). A 1:100 dilution of rabbit polyclonal antiserum to BopE78-261 was used, and bound antibody was detected with an anti-rabbit alkaline phosphatase conjugate. As expected, BopE was detected in whole-cell extracts of all strains except the 10276 bopE mutant (Fig. 1A). BopE secretion was dependent on the Bsa type III secretion apparatus, as no secretion was observed in a bsaZ mutant (Fig. 1B). In contrast, BopE secretion was elevated in B. pseudomallei lacking the putative translocator BipD (Fig. 1B). These data are consistent with the observation that Salmonella sip mutants secrete elevated levels of selected Sops (15, 35). Thus, our data suggest that the B. pseudomallei Bsa type III secretion apparatus is functional and that BopE is type III secreted.
BopE facilitates invasion of nonphagocytic cells.
B. pseudomallei can invade and survive within nonphagocytic
cells (
14,
16). To assess the role of BopE in bacterial invasion,
we quantified intracellular
B. pseudomallei following infection
of HeLa cells by strains 10276, 10276
bipD, and 10276
bopE by
using a kanamycin protection assay. Previously we have been
unable to detect significant invasion of HeLa cells by
B. pseudomallei strain 10276 (
31); however, we have found that invasion efficiency
can be improved by centrifugation of the bacteria onto cell
monolayers at 300
x g at the onset of infection. HeLa cells
maintained in RPMI 1640 containing 10% (vol/vol) fetal calf
serum were infected at a multiplicity of 10 with
B. pseudomallei strains grown to stationary phase in Luria-Bertani broth at
37°C in a humidified 5% CO
2 atmosphere. One hour after bacterial
inoculation, monolayers were washed three times and overlaid
with medium containing kanamycin (250 µg/ml) to kill extracellular
bacteria. After 6 h viable intracellular bacteria were released
by gentle lysis using 0.1% Triton X-100 and enumerated by plating
of serial dilutions. We detected a statistically significant
reduction in invasion of HeLa cells by the 10276
bopE mutant
compared to that of the wild type (
P = 0.0464) (Fig.
2), indicating
that BopE, like
Salmonella SopE/SopE2, facilitates bacterial
invasion of nonphagocytic cells. SopE acts in concert with other
type III secreted proteins to promote
Salmonella invasion (
38).
Recently it was reported that the effector protein SopB, which
possesses phosphatidylinositol phosphatase activity, influences
Salmonella invasion (
24,
39). It is likely that other type III
secreted proteins influence invasion of nonphagocytic cells
by
B. pseudomallei. Consistent with this hypothesis we detected
a highly significant reduction in invasion of HeLa cells by
the 10276
bipD mutant (
P = 0.0058).
B. pseudomallei is a Centers
for Disease Control and Prevention category B critical biological
agent, and we were unable to
trans-complement the
bopE mutation
owing to restrictions on genetic modification of the organism.
BopE expressed in eukaryotic cells induces rearrangements in the subcortical actin cytoskeleton.
To assess the activity of BopE in eukaryotic cells, we amplified
the entire coding sequence of
bopE using the primers BopEpRKBam
(5'-CTC
GGATCCATGACTTACAACCCGAGAATCGGCGG-3') and BopEpRKE1 (5'-CTC
GAATTCTCACGCGCCGTCCGCCGCGTTCGTCGC-3')
and cloned the product into pRK5
myc (
17) via
EcoRI and
BamHI
(underlined) sites. This created a BopE fusion protein with
a
myc tag at the N terminus. As a control the
Salmonella enterica serovar Typhimurium
sopE gene was cloned into pRK5
myc in the
same way using the primers SopEpRKBam (5'-CTC
GGATCCGTGACAAAAATAACTTTATTTCC-3')
and SopEpRKE1 (5'-CTC
GAATTCTCAGGGAGTGTTTTGGATATATT-3'). HeLa
cells were transfected with pRK5
myc-BopE or pRK5
myc-SopE by
using Lipofectamine (Invitrogen Life Technologies, Paisley,
United Kingdom). Twenty-four hours after transfection, cells
were stained for the presence of the
myc-tagged protein with
a mouse monoclonal
myc-specific antibody (Invitrogen) detected
with anti-mouse Alexa
488 conjugate (Molecular Probes, Leiden,
The Netherlands). Filamentous actin was stained using tetramethyl
rhodamine isothiocyanate-conjugated phalloidin and the cells
were viewed using a Leica TCS NT confocal laser scanning microscope.
In cells expressing the
myc-tagged BopE and SopE proteins filamentous
actin was abundant under the membrane and was associated with
areas of "ruffling" (Fig.
3), suggesting that the proteins interfere
with actin dynamics in eukaryotic cells. Such rearrangements
were not detected in nontransfected cells present in the same
field. Some SopE and BopE appeared to colocalize with regions
of intense F-actin staining in membrane ruffles (Fig.
3).
BopE is a GEF.
To determine if BopE possesses GEF activity, we employed fluorescence
spectrometry using mGDP-loaded Rac1 (Fig.
4A) or Cdc42 (Fig.
4B) as a substrate (
8). mGDP is a GDP derivative which is popular
for kinetic studies because the fluorescence intensity of the
mant moiety changes dramatically upon binding to GTPases. mGDP
bound to Cdc42 has a fourfold-higher fluorescence intensity
than unbound mGDP (
20,
27,
28). Generally, the presence of the
fluorophore has little effect on the kinetic parameters of G
nucleotide release or GTP hydrolysis (
7,
18,
19,
20,
32).
BopE
78-261 was expressed and purified as described above and
mGDP-Rac1 or mGDP-Cdc42 was prepared as described previously
(
8,
9). In the assay buffer (no EDTA or BopE) mGDP dissociation
from Rac1 was very slow. In contrast, fast dissociation of the
mGDP-Rac1 complex was observed in the presence of 25 nM BopE
and even faster in the presence of 250 nM BopE (Fig.
4A) (
kobs = 0.48 s
-1). Similar observations were made using mGDP-Cdc42
as a substrate (Fig.
4B). These data demonstrate that BopE is
an efficient GEF for Cdc42 and Rac1. The observed G-nucleotide
exchange rates are lower than those observed with SopE from
Salmonella serovar Typhimurium (
8) but range in the same order
of magnitude.
Taken together our observations suggest that B. pseudomallei enters epithelial cells by a mechanism dependent at least in part upon the Bsa type III protein secretion apparatus and one of its secreted proteins, BopE. It is likely that BopE is translocated into the host cell cytosol, where it may promote membrane ruffling by acting as a GEF for Cdc42 and Rac1. In Salmonella several Inv/Spa/Prg-secreted proteins (SopE, SopE2, and SopB) act in concert to promote bacterial uptake by nonphagocytic cells (38, 39), and Salmonella invasion probably evolved through the acquisition of new sequence elements (22). Given that a B. pseudomallei bipD mutant was impaired in invasion of HeLa cells to a greater extent than a bopE mutant, it is likely that other Bsa-secreted proteins may be involved in bacterial uptake. We are investigating the role of other putative type III secreted proteins in the host-cell interactions of B. pseudomallei.

FOOTNOTES
* Corresponding author. Mailing address: Division of Environmental Microbiology, Institute for Animal Health, Compton Laboratory, Berkshire RG20 7NN, United Kingdom. Phone: 44 1635 577291. Fax: 44 1635 577243. E-mail:
edouard.galyov{at}bbsrc.ac.uk.

Present address: Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom. 

REFERENCES
1 - Attree, O., and I. Attree. 2001. A second type III secretion system in Burkholderia pseudomallei: who is the real culprit? Microbiology 147:3197-3199.[Free Full Text]
2 - Bakshi, C. S., V. P. Singh, M. W. Wood, P. W. Jones, T. S. Wallis, and E. E. Galyov. 2000. Identification of SopE2, a Salmonella secreted protein which is highly homologous to SopE and involved in bacterial invasion of epithelial cells. J. Bacteriol. 82:2341-2344.
3 - Brett, P. J., and D. E. Woods. 2000. Pathogenesis of and immunity to melioidosis. Acta Trop. 74:201-210.[CrossRef][Medline]
4 - Chaowagul, W., Y. Suputtamongkol, D. A. B. Dance, A. Rajchanuvong, J. Pattaraarechachai, and N. J. White. 1993. Relapse in melioidosis: incidence and risk factors. J. Infect. Dis. 168:1181-1185.[Medline]
5 - Cornelis, G. R., and F. van Gijsegem. 2000. Assembly and function of type III secretion systems. Annu. Rev. Microbiol. 54:735-774.[CrossRef][Medline]
6 - Dance, D. A. 2000. Melioidosis is an emerging global problem. Acta Trop. 74:115-119.[CrossRef][Medline]
7 - Franken, S. M., A. J. Scheidig, U. Krengel, H. Rensland, A. Lautwein, M. Geyer, K. Scheffzek, R. S. Goody, H. R. Kalbitzer, E. F. Pai, et al. 1993. Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras. Biochemistry 32:8411-8420.[CrossRef][Medline]
8 - Friebel, A., H. Ilchmann, M. Aepfelbacher, K. Ehrbar, W. Machleidt, and W.-D. Hardt. 2001. SopE and SopE2 from Salmonella typhimurium activate different sets of RhoGTPases of the host cell. J. Biol. Chem. 276:34035-34040.[Abstract/Free Full Text]
9 - Friebel, A., and W.-D. Hardt. 2000. Purification and biochemical activity of Salmonella exchange factor SopE. Methods Enzymol. 325:82-91.[Medline]
10 - Galán, J. E. 2001. Salmonella interactions with host cells: type III secretion at work. Annu. Rev. Cell. Dev. Biol. 17:53-86.[CrossRef][Medline]
11 - Galyov, E. E., M. W. Wood, R. Rosqvist, P. B. Mullan, P. R. Watson, S. Hedges, and T. S. Wallis. 1997. A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa. Mol. Microbiol. 25:903-912.[CrossRef][Medline]
12 - Hardt, W.-D., L. M. Chen, K. E. Schuebel, X. R. Bustelo, and J. E. Galán. 1998. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93:815-826.[CrossRef][Medline]
13 - Hueck, C. J. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:379-433.[Abstract/Free Full Text]
14 - Jones, A. L., T. J. Beveridge, and D. E. Woods. 1996. Intracellular survival of Burkholderia pseudomallei. Infect. Immun. 64:782-790.[Abstract]
15 - Kaniga, K., D. Trollinger, and J. E. Galán. 1995. Identification of two targets of the type III protein secretion system encoded by the inv and spa loci of Salmonella typhimurium that have homology to the Shigella IpaD and IpaA proteins. J. Bacteriol. 177:7078-7085.[Abstract/Free Full Text]
16 - Kespichayawattana, W., S. Rattanachetkul, T. Wanun, P. Utaisincharoen, and S. Sirisinha. 2000. Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism of cell-to-cell spreading. Infect. Immun. 68:5377-5384.[Abstract/Free Full Text]
17 - Lamarche, N., N. Tapon, L. Stowers, P. D. Burbelo, P. Aspenstrom, T. Bridges, J. Chant, and A. Hall. 1996. Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell 87:519-529.[CrossRef][Medline]
18 - Lenzen, C., R. H. Cool, and A. Wittinghofer. 1995. Analysis of intrinsic and CDC25-stimulated guanine nucleotide exchange of p21ras-nucleotide complexes by fluorescence measurements. Methods Enzymol. 255:95-109.[Medline]
19 - Lenzen, C., R. H. Cool, H. Prinz, J. Kuhlmann, and A. Wittinghofer. 1998. Kinetic analysis by fluorescence of the interaction between Ras and the catalytic domain of the guanine nucleotide exchange factor Cdc25Mm. Biochemistry 37:7420-7430.[CrossRef][Medline]
20 - Leonard, D. A., T. Evans, M. Hart, R. A. Cerione, and D. Manor. 1994. Investigation of the GTP-binding/GTPase cycle of Cdc42Hs using fluorescence spectroscopy. Biochemistry 33:12323-12328.[CrossRef][Medline]
21 - Mays, E. E., and E. A. Ricketts. 1975. Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure. Chest 68:261-263.[Abstract/Free Full Text]
22 - Mirold, S., K. Ehrbar, A. Weissmuller, R. Prager, H. Tschape, H. Russmann, and W.-D. Hardt. 2001. Salmonella host cell invasion emerged by acquisition of a mosaic of separate genetic elements, including Salmonella pathogenicity island 1 (SPI1), SPI5, and sopE2. J. Bacteriol. 183:2348-2358.[Abstract/Free Full Text]
23 - Mukherjee, K., S. Parashuraman, M. Raje, and A. Mukhopadhyay. 2001. SopE acts as an Rab5-specific nucleotide exchange factor and recruits non-prenylated Rab5 on Salmonella-containing phagosomes to promote fusion with early endosomes. J. Biol. Chem. 276:23607-23615.[Abstract/Free Full Text]
24 - Norris, F. A., M. P. Wilson, T. S. Wallis, E. E. Galyov, and P. W. Majerus. 1998. SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphatase. Proc. Natl. Acad. Sci. USA 95:14057-14059.[Abstract/Free Full Text]
25 - Pruksachartvuthi, S., N. Aswapokee, and K. Thankerngpol. 1990. Survival of Pseudomonas pseudomallei in human phagocytes. J. Med. Microbiol. 31:109-114.[Abstract/Free Full Text]
26 - Rainbow, L., C. A. Hart, and C. Winstanley. 2002. Distribution of type III secretion gene clusters in Burkholderia pseudomallei, B. thailandensis and B. mallei. J. Med. Microbiol. 51:374-384.[Abstract/Free Full Text]
27 - Rudolph, M. G., C. Weise, S. Mirold, B. Hillenbrand, B. Bader, A. Wittinghofer, and W.-D. Hardt. 1999. Biochemical analysis of SopE from Salmonella typhimurium, a highly efficient guanosine nucleotide exchange factor for RhoGTPases. J. Biol. Chem. 274:30501-30509.[Abstract/Free Full Text]
28 - Rudolph, M. G., P. Bayer, A. Abo, J. Kuhlmann, I. R. Vetter, and A. Wittinghofer. 1998. The Cdc42/Rac interactive binding region motif of the Wiskott Aldrich syndrome protein (WASP) is necessary but not sufficient for tight binding to Cdc42 and structure formation. J. Biol. Chem. 273:18067-18076.[Abstract/Free Full Text]
29 - Sansonetti, P. J. 2001. Rupture, invasion and inflammatory destruction of the intestinal barrier by Shigella, making sense of prokaryote-eukaryote cross-talks. FEMS Microbiol. Rev. 25:3-14.[Medline]
30 - Stender, S., A. Friebel, S. Linder, M. Rohde, S. Mirold, and W.-D. Hardt. 2000. Identification of SopE2 from Salmonella typhimurium, a conserved guanine nucleotide exchange factor for Cdc42 of the host cell. Mol. Microbiol. 36:1206-1221.[CrossRef][Medline]
31 - Stevens, M. P., M. W. Wood, L. A. Taylor, P. Monaghan, P. Hawes, P. W. Jones, T. S. Wallis, and E. E. Galyov. 2002. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behavior of the pathogen. Mol. Microbiol. 46:649-659.[CrossRef][Medline]
32 - Tan, Y. C., H. Wu, W. N. Wang, Y. Zheng, and Z. X. Wang. 2002. Characterization of the interactions between the small GTPase RhoA and its guanine nucleotide exchange factors. Anal. Biochem. 310:156-162.[CrossRef][Medline]
33 - Wallis, T. S., and E. E. Galyov. 2000. Molecular basis of Salmonella-induced enteritis. Mol. Microbiol. 36:997-1005.[CrossRef][Medline]
34 - Wood, M. W., M. A. Jones, P. R. Watson, A. M. Siber, B. A. McCormick, S. Hedges, R. Rosqvist, T. S. Wallis, and E. E. Galyov. 2000. The secreted effector protein of Salmonella dublin, SopA, is translocated into eukaryotic cells and influences the induction of enteritis. Cell. Microbiol. 2:293-303.[CrossRef][Medline]
35 - Wood, M. W., R. Rosqvist, P. B. Mullan, M. H. Edwards, and E. E. Galyov. 1996. SopE, a secreted protein of Salmonella dublin, is translocated into the target eukaryotic cell via a Sip-dependent mechanism and promotes bacterial entry. Mol. Microbiol. 22:327-338.[CrossRef][Medline]
36 - Zhang, S., R. A. Kingsley, R. L. Santos, H. Andrews-Polymenis, M. Raffatellu, J. Figueiredo, J. Nunes, R. M. Tsolis, L. G. Adams, and A. J. Baumler. 2003. Molecular pathogenesis of Salmonella enterica serotype Typhimurium-induced diarrhea. Infect. Immun. 71:1-12.[Free Full Text]
37 - Zhang, S., R. L. Santos, R. M. Tsolis, S. Mirold, W.-D. Hardt, L. G. Adams, and A. J. Baumler. 2002. Phage mediated horizontal transfer of the sopE1 gene increases enteropathogenicity of Salmonella enterica serotype Typhimurium for calves. FEMS Microbiol. Lett. 217:243-247.[CrossRef][Medline]
38 - Zhou, D., and J. Galán. 2001. Salmonella entry into host cells: the work in concert of type III secreted effector proteins. Microbes Infect. 3:1293-1298.[CrossRef][Medline]
39 - Zhou, D., L. M. Chen, L. Hernandez, S. B. Shears, and J. E. Galán. 2001. A Salmonella inositol polyphosphatase acts in conjunction with other bacterial effectors to promote host cell actin cytoskeleton rearrangements and bacterial internalization. Mol. Microbiol. 39:248-259.[CrossRef][Medline]
Journal of Bacteriology, August 2003, p. 4992-4996, Vol. 185, No. 16
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.16.4992-4996.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Lamothe, J., Valvano, M. A.
(2008). Burkholderia cenocepacia-induced delay of acidification and phagolysosomal fusion in cystic fibrosis transmembrane conductance regulator (CFTR)-defective macrophages. Microbiology
154: 3825-3834
[Abstract]
[Full Text]
-
Haraga, A., West, T. E., Brittnacher, M. J., Skerrett, S. J., Miller, S. I.
(2008). Burkholderia thailandensis as a Model System for the Study of the Virulence-Associated Type III Secretion System of Burkholderia pseudomallei. Infect. Immun.
76: 5402-5411
[Abstract]
[Full Text]
-
Kaestli, M., Mayo, M., Harrington, G., Watt, F., Hill, J., Gal, D., Currie, B. J.
(2007). Sensitive and Specific Molecular Detection of Burkholderia pseudomallei, the Causative Agent of Melioidosis, in the Soil of Tropical Northern Australia. Appl. Environ. Microbiol.
73: 6891-6897
[Abstract]
[Full Text]
-
Shalom, G., Shaw, J. G., Thomas, M. S.
(2007). In vivo expression technology identifies a type VI secretion system locus in Burkholderia pseudomallei that is induced upon invasion of macrophages. Microbiology
153: 2689-2699
[Abstract]
[Full Text]
-
Rodrigues, F., Sarkar-Tyson, M., Harding, S. V., Sim, S. H., Chua, H. H., Lin, C. H., Han, X., Karuturi, R. K. M., Sung, K., Yu, K., Chen, W., Atkins, T. P., Titball, R. W., Tan, P.
(2006). Global Map of Growth-Regulated Gene Expression in Burkholderia pseudomallei, the Causative Agent of Melioidosis. J. Bacteriol.
188: 8178-8188
[Abstract]
[Full Text]
-
Ribot, W. J., Ulrich, R. L.
(2006). The Animal Pathogen-Like Type III Secretion System Is Required for the Intracellular Survival of Burkholderia mallei within J774.2 Macrophages. Infect. Immun.
74: 4349-4353
[Abstract]
[Full Text]
-
Pilatz, S., Breitbach, K., Hein, N., Fehlhaber, B., Schulze, J., Brenneke, B., Eberl, L., Steinmetz, I.
(2006). Identification of Burkholderia pseudomallei Genes Required for the Intracellular Life Cycle and In Vivo Virulence.. Infect. Immun.
74: 3576-3586
[Abstract]
[Full Text]
-
Troisfontaines, P., Cornelis, G. R.
(2005). Type III Secretion: More Systems Than You Think. Physiology
20: 326-339
[Abstract]
[Full Text]
-
Suparak, S., Kespichayawattana, W., Haque, A., Easton, A., Damnin, S., Lertmemongkolchai, G., Bancroft, G. J., Korbsrisate, S.
(2005). Multinucleated Giant Cell Formation and Apoptosis in Infected Host Cells Is Mediated by Burkholderia pseudomallei Type III Secretion Protein BipB. J. Bacteriol.
187: 6556-6560
[Full Text]
-
Cheng, A. C., Currie, B. J.
(2005). Melioidosis: Epidemiology, Pathophysiology, and Management. Clin. Microbiol. Rev.
18: 383-416
[Abstract]
[Full Text]
-
Essex-Lopresti, A. E., Boddey, J. A., Thomas, R., Smith, M. P., Hartley, M. G., Atkins, T., Brown, N. F., Tsang, C. H., Peak, I. R. A., Hill, J., Beacham, I. R., Titball, R. W.
(2005). A Type IV Pilin, PilA, Contributes to Adherence of Burkholderia pseudomallei and Virulence In Vivo. Infect. Immun.
73: 1260-1264
[Abstract]
[Full Text]
-
Thibault, F. M., Valade, E., Vidal, D. R.
(2004). Identification and Discrimination of Burkholderia pseudomallei, B. mallei, and B. thailandensis by Real-Time PCR Targeting Type III Secretion System Genes. J. Clin. Microbiol.
42: 5871-5874
[Abstract]
[Full Text]
-
Stevens, M. P., Haque, A., Atkins, T., Hill, J., Wood, M. W., Easton, A., Nelson, M., Underwood-Fowler, C., Titball, R. W., Bancroft, G. J., Galyov, E. E.
(2004). Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology
150: 2669-2676
[Abstract]
[Full Text]